Lei Lei Wu - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Lei Lei Wu's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Lei Lei Wu

Lei Lei Wu

Verified

News Reporter, Endpoints News

New Jersey, Princeton Junction

Final Covers

fitness and wellness

Doesn’t Cover

Journalist Type

-

Seniority Positions

-

Industries

Medium Formats

-

Content

Total articles 541

  • Regeneron, two Chinese biotechs tout promise of their hearing loss gene therapies

    By Lei Lei Wu Verified

    Feb. 26, 2025

  • Candel’s viral therapy shows promising survival in small pancreatic cancer study

    By Lei Lei Wu Verified

    Feb. 25, 2025

  • Regeneron, two Chinese biotechs tout promise of their hearing loss gene therapies

    By Lei Lei Wu Verified

    Feb. 26, 2025

As seen in

Company Info

Endpoints News

Endpoints News is an independent news organization dedicated to the biopharmaceutical industry. Founded in 2016 by Arsalan Arif and John Carroll, it has established itself as a trusted source of information, boasting over 163,000 subscribers, including executives and scientific leaders from top pharmaceutical companies and biotech startups worldwide. The organization provides daily news reports, analysis, and events tailored for biopharma professionals. Its offerings include daily newsletters like the Early Edition, investigative reporting on drug development and regulatory updates, and in-person and virtual conferences such as the Endpoints Summit. Endpoints News emphasizes independent journalism and operates on a subscription model, providing premium content to subscribers while maintaining ad-free reporting. With a focus on both scientific and business aspects of the industry, it serves decision-makers across the global pharmaceutical landscape.

Lawrence, Kansas, United States

+1 785-813-1733

Founded: 2014